Fundies.
English

Segment disclosures

Company overview

Portola Pharmaceuticals, Inc

Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.

Revenue · Reported segment facts

4 dimension combinations 20 retained observations 3 reported periods

Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.

Collaboration And License Revenue

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=ptla:CollaborationAndLicenseRevenueMember
PeriodValueUnitFiledEvidence
2018-07-01 – 2018-09-307001000 USD20181107Open filing evidence
2018-01-01 – 2018-09-3014785000 USD20181107Open filing evidence
2018-04-01 – 2018-06-301746000 USD20180809Open filing evidence
2018-01-01 – 2018-06-307784000 USD20180809Open filing evidence
2018-01-01 – 2018-03-316038000 USD20180510Open filing evidence

Net Product Revenue

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=ptla:NetProductRevenueMember
PeriodValueUnitFiledEvidence
2018-07-01 – 2018-09-307176000 USD20181107Open filing evidence
2018-01-01 – 2018-09-3010047000 USD20181107Open filing evidence
2018-04-01 – 2018-06-302265000 USD20180809Open filing evidence
2018-01-01 – 2018-06-302871000 USD20180809Open filing evidence
2018-01-01 – 2018-03-31606000 USD20180510Open filing evidence

Transferred At Point In Time · Net Product Revenue

Timing Of Transfer Of Good Or Service · Statement Business Segments

Source dimensions us-gaap:TimingOfTransferOfGoodOrServiceAxis=us-gaap:TransferredAtPointInTimeMember;us-gaap:StatementBusinessSegmentsAxis=ptla:NetProductRevenueMember
PeriodValueUnitFiledEvidence
2018-07-01 – 2018-09-307176000 USD20181107Open filing evidence
2018-01-01 – 2018-09-3010047000 USD20181107Open filing evidence
2018-04-01 – 2018-06-302265000 USD20180809Open filing evidence
2018-01-01 – 2018-06-302871000 USD20180809Open filing evidence
2018-01-01 – 2018-03-31606000 USD20180510Open filing evidence

Transferred Over Time · Collaboration And License Revenue

Timing Of Transfer Of Good Or Service · Statement Business Segments

Source dimensions us-gaap:TimingOfTransferOfGoodOrServiceAxis=us-gaap:TransferredOverTimeMember;us-gaap:StatementBusinessSegmentsAxis=ptla:CollaborationAndLicenseRevenueMember
PeriodValueUnitFiledEvidence
2018-07-01 – 2018-09-307001000 USD20181107Open filing evidence
2018-01-01 – 2018-09-3014785000 USD20181107Open filing evidence
2018-04-01 – 2018-06-301746000 USD20180809Open filing evidence
2018-01-01 – 2018-06-307784000 USD20180809Open filing evidence
2018-01-01 – 2018-03-316038000 USD20180510Open filing evidence